Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Barinthus Biotherapeutics (BRNS) Preferred Shares Issued (2021)

Barinthus Biotherapeutics (BRNS) has disclosed Preferred Shares Issued for 1 consecutive years, with $125.2 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Preferred Shares Issued changed N/A year-over-year to $125.2 million, compared with a TTM value of $125.2 million through Dec 2021, changed N/A, and an annual FY2021 reading of $125.2 million, changed N/A over the prior year.
  • Preferred Shares Issued was $125.2 million for Q1 2021 at Barinthus Biotherapeutics.
  • Across five years, Preferred Shares Issued topped out at $125.2 million in Q1 2021 and bottomed at $125.2 million in Q1 2021.